22 employees
Spatial Genomics is a developer of sequential fluorescence in situ hybridization (seqFISH) technology.
2016
$56M
from 1 investors over 1 rounds
Spatial Genomics, Inc. raised $56M on February 23, 2022
Investors: Fulgent Diagnostics